Tickers

1. Composite Trajectory Verdict

Given HAWK's capital-intensive satellite constellation model, high upfront R&D and acquisition integration costs, and government-contract revenue profile, all three statements carry roughly equal weight: the income statement shows whether contract pricing covers full operating costs, the cash flow statement reveals whether operations self-fund satellite capex, and the balance sheet reflects leverage, liquidity, and backlog visibility.

Composite Trajectory: Mixed

Revenue is accelerating (101% YoY for six months ended June 30, 2026 vs. 2025; 87% YoY for Q2 2026 vs. Q2 2025) but GAAP profitability has collapsed (six-month net loss of $24.3M vs. $20K income; Q2 net loss of $15.3M vs. $1.6M income). Operating cash flow improved markedly (six months $8.4M inflow vs. $2.9M outflow; Q1 $3.3M outflow vs. $7.5M outflow), and the IPO transformed the balance sheet (cash $503.4M vs. $92.7M; debt eliminated; equity $794.8M vs. -$106.5M deficit). Backlog dipped slightly ($292.2M at June 30 vs. $302.7M at Dec 31). The trajectory is therefore mixed: top-line and liquidity/balance-sheet metrics are improving, while GAAP margins and earnings are deteriorating.

2. Red Flags

• GAAP operating margin collapsed despite revenue doubling: Q2 2026 operating loss $11.5M on $49.8M revenue (-23.2%) vs. Q2 2025 operating income $0.8M on $26.6M revenue (+3.0%) (10-Q 2026-06-30, Condensed Statements of Operations).
• Direct cost of sales as % of revenue jumped: from 19% (Q2 2025) to 30% (Q2 2026) and from 20% (six months 2025) to 31% (six months 2026), driven by ISA acquisition headcount (10-Q 2026-06-30, MD&A).
• SG&A surged 184% YoY in Q2 and 158% YoY for six months, outpacing revenue growth, due to stock-based compensation and professional services (10-Q 2026-06-30, MD&A).
• Net loss widened to $24.3M for six months 2026 from $20K income in 2025, with non-cash fair-value losses on warrants ($4.5M) and contingent consideration ($1.2M) and a $2.7M debt extinguishment loss (10-Q 2026-06-30, Condensed Statements of Operations).
• Backlog declined sequentially: $302.7M (Dec 31, 2025) → $285.0M (Mar 31, 2026) → $292.2M (Jun 30, 2026) (10-Q 2026-06-30, MD&A; 10-Q 2026-03-31, MD&A).
• Customer concentration: Customer G represented 27% of accounts receivable at June 30, 2026 (up from <10% at Dec 31, 2025); Customer A 15% of Q2 2026 revenue (10-Q 2026-06-30, Note 2).
• Large non-GAAP adjustments recurring: stock-based compensation $9.8M (six months 2026) vs. $1.8M (2025); warrant fair-value losses $4.5M vs. $0.5M; acquisition costs $1.6M vs. $0 (10-Q 2026-06-30, Adjusted EBITDA reconciliation).

3. Earnings Assessment (Income Statement)

Earnings Trajectory: Deteriorating

Revenue grew 101% YoY for six months ended June 30, 2026 ($99.6M vs. $49.6M) and 87% YoY for Q2 ($49.8M vs. $26.6M), driven by the ISA acquisition ($29.3M six-month / $14.4M Q2 contribution) and international RF data sales (10-Q 2026-06-30, MD&A). However, GAAP profitability deteriorated sharply: six-month net loss $24.3M vs. $20K income; Q2 net loss $15.3M vs. $1.6M income. Operating loss widened to $17.2M (six months) and $11.5M (Q2) from -$1.3M and +$0.8M respectively. Direct cost of sales rose to 31% of revenue (six months) and 30% (Q2) from 20% and 19%, while SG&A jumped to 43% and 50% of revenue from 34% and 33%. Depreciation/amortization increased 51% YoY (six months) due to ISA intangible amortization ($3.5M) and satellite depreciation ($0.9M). Interest expense rose to $2.3M (six months) from $35K on the 2025 Loans. Fair-value losses on warrants ($4.5M) and contingent consideration ($1.2M) plus a $2.7M debt extinguishment loss further depressed net income.

4. Cash Generation Assessment (Statement of Cash Flows)

Cash Trajectory: Improving

Operating cash flow turned positive for the six months ended June 30, 2026 at $8.4M vs. -$2.9M in 2025, driven by favorable working capital movements (contract liabilities +$10.5M, related-party receivables +$21.0M) and higher non-cash expenses (stock-based comp $9.8M, D&A $16.4M, warrant fair-value loss $4.5M) partially offset by the larger net loss (10-Q 2026-06-30, Condensed Statements of Cash Flows). Q1 2026 operating cash outflow narrowed to $3.3M from $7.5M in Q1 2025 (10-Q 2026-03-31, Condensed Statements of Cash Flows). Free Cash Flow (non-GAAP) improved to -$1.9M (six months) and +$5.4M (Q2) from -$12.0M and -$1.3M respectively, though capex remained elevated at $10.3M (six months) and $6.2M (Q2) for satellite/property/equipment (10-Q 2026-06-30, MD&A). Financing cash flow surged to $413.0M from IPO proceeds ($478.4M) less debt repayment ($49.5M) and offering costs ($37.8M). Investing cash flow was -$10.3M (six months) vs. +$30.6M in 2025, the prior period benefiting from $39.7M short-term investment redemptions.

5. Balance Sheet Assessment

Balance Sheet Trajectory: Improving

The IPO and debt repayment dramatically strengthened the balance sheet. Cash and equivalents rose to $503.4M at June 30, 2026 from $92.7M at Dec 31, 2025 and $106.1M at Mar 31, 2026 (10-Q 2026-06-30, Balance Sheet; 10-Q 2026-03-31, Balance Sheet). Long-term debt was eliminated ($0 vs. $46.3M at Dec 31 and $46.6M at Mar 31). Total liabilities fell to $109.4M from $148.9M. Mezzanine equity (preferred stock) converted to common, moving $447.6M to equity. Stockholders' equity swung to $794.8M from -$106.5M deficit. Total assets nearly doubled to $904.2M from $489.9M. Contract liabilities (deferred revenue) grew to $33.6M from $23.2M. Goodwill increased to $118.0M from $116.9M on ISA purchase-price adjustments. The $125M revolving credit facility was undrawn at June 30. Backlog dipped to $292.2M from $302.7M at Dec 31.

6. Data Gaps

• Stand-alone Q2 2025 income statement (only six-month and Q2 2026 vs. Q2 2025 comparisons provided; Q1 2025 figures embedded in six-month 2025 but not separately presented in the 2026-06-30 filing).
• Quarterly cash flow statements for Q2 2026 and Q2 2025 (only six-month and Q1 periods presented in the filings).
• Full-year 2025 audited financials (referenced but not included in the provided documents).
• Detailed segment or product-line revenue breakdown beyond U.S./International and timing categories.
• Covenant compliance metrics (Total Net Leverage Ratio, Interest Coverage Ratio) for the 2026 Credit Facility beyond management's assertion of compliance.
• ISA standalone financials for periods prior to acquisition (only post-acquisition revenue/loss for three and six months ended June 30, 2026 disclosed in Note 3).